Jayedi A, Soltani S, Motlagh SZ, Emadi A, Shahinfar H, Moosavi H, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022;376:e067516. https://doi.org/10.1136/bmj-2021-067516.
Article PubMed PubMed Central Google Scholar
Chartrand DJ, Murphy-Despres A, Almeras N, Lemieux I, Larose E, Despres JP. Overweight, obesity, and CVD risk: a focus on visceral/ectopic fat. Curr Atheroscler Rep. 2022;24(4):185–95. https://doi.org/10.1007/s11883-022-00996-x.
Mende CW, Einhorn D. Fatty kidney disease: a new renal and endocrine clinical entity? Describing the role of the kidney in obesity, metabolic syndrome, and type 2 diabetes. Endocr Pract. 2019;25(8):854–8. https://doi.org/10.4158/EP-2018-0568.
Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus-mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. https://doi.org/10.1038/s41575-021-00448-y.
Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22(7):429–43. https://doi.org/10.1038/s41577-021-00639-3.
Article CAS PubMed Google Scholar
de la Rosa Rodriguez MA, Kersten S. Regulation of lipid droplet-associated proteins by peroxisome proliferator-activated receptors. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(10 Pt B):1212–20. https://doi.org/10.1016/j.bbalip.2017.07.007.
Article CAS PubMed Google Scholar
Ibarguren M, Lopez DJ, Escriba PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta. 2014;1838(6):1518–28. https://doi.org/10.1016/j.bbamem.2013.12.021.
Article CAS PubMed Google Scholar
Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13(10):572–87. https://doi.org/10.1038/nrendo.2017.80.
Article CAS PubMed PubMed Central Google Scholar
Rorsman P, Ashcroft FM. Pancreatic beta-cell electrical activity and insulin secretion: of mice and men. Physiol Rev. 2018;98(1):117–214. https://doi.org/10.1152/physrev.00008.2017.
Article CAS PubMed Google Scholar
Guglielmi V, Sbraccia P. Type 2 diabetes: Does pancreatic fat really matter? Diabetes Metab Res Rev. 2018;34(2). https://doi.org/10.1002/dmrr.2955.
Maya-Monteiro CM, Correa-da-Silva F, Hofmann SS, Hesselink MKC, la Fleur SE, Yi CX. Lipid droplets accumulate in the hypothalamus of mice and humans with and without metabolic diseases. Neuroendocrinology. 2021;111(3):263–72. https://doi.org/10.1159/000508735.
Article CAS PubMed Google Scholar
Bhusal A, Rahman MH, Suk K. Hypothalamic inflammation in metabolic disorders and aging. Cell Mol Life Sci. 2021;79(1):32. https://doi.org/10.1007/s00018-021-04019-x.
Article CAS PubMed Google Scholar
Frayn KN. Non-esterified fatty acid metabolism and postprandial lipaemia. Atherosclerosis. 1998;141(Suppl 1):S41–6. https://doi.org/10.1016/s0021-9150(98)00216-0.
Article CAS PubMed Google Scholar
Dragano NR, Monfort-Pires M, Velloso LA. Mechanisms mediating the actions of fatty acids in the hypothalamus. Neuroscience. 2020;447:15–27. https://doi.org/10.1016/j.neuroscience.2019.10.012.
Article CAS PubMed Google Scholar
Timper K, Bruning JC. Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity. Dis Model Mech. 2017;10(6):679–89. https://doi.org/10.1242/dmm.026609.
Article CAS PubMed PubMed Central Google Scholar
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S158–90. https://doi.org/10.2337/dc23-S010.
Article CAS PubMed Google Scholar
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 11. Chronic kidney disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S191–202. https://doi.org/10.2337/dc23-S011.
Article CAS PubMed Google Scholar
Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018;17(1):218. https://doi.org/10.1186/s12944-018-0856-8.
Article CAS PubMed PubMed Central Google Scholar
Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593–606. https://doi.org/10.1038/s41569-022-00679-9.
Article CAS PubMed PubMed Central Google Scholar
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15(6):367–85. https://doi.org/10.1038/s41581-019-0145-4.
Article PubMed PubMed Central Google Scholar
Grabner GF, Xie H, Schweiger M, Zechner R. Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab. 2021;3(11):1445–65. https://doi.org/10.1038/s42255-021-00493-6.
Article CAS PubMed Google Scholar
Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984–1010. https://doi.org/10.1161/CIR.0000000000000973.
Article PubMed PubMed Central Google Scholar
Thompson B, Waterhouse M, English DR, McLeod DS, Armstrong BK, Baxter C, et al. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial. BMJ. 2023;381:e075230. https://doi.org/10.1136/bmj-2023-075230.
Article PubMed PubMed Central Google Scholar
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S128–39. https://doi.org/10.2337/dc23-S008.
Article CAS PubMed Google Scholar
Jayedi A, Zeraattalab-Motlagh S, Shahinfar H, Gregg EW, Shab-Bidar S. Effect of calorie restriction in comparison to usual diet or usual care on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2023;117(5):870–82. https://doi.org/10.1016/j.ajcnut.2023.03.018.
Article CAS PubMed Google Scholar
Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308(23):2489–96. https://doi.org/10.1001/jama.2012.67929.
Article CAS PubMed PubMed Central Google Scholar
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541–51. https://doi.org/10.1016/S0140-6736(17)33102-1.
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 2019;7(5):344–55. https://doi.org/10.1016/S2213-8587(19)30068-3.
Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jonsson T, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ. 2021;372:m4743. https://doi.org/10.1136/bmj.m4743.
Article PubMed PubMed Central Google Scholar
Batch JT, Lamsal SP, Adkins M, Sultan S, Ramirez MN. Advantages and disadvantages of the ketogenic diet: a review article. Cureus. 2020;12(8):e9639. https://doi.org/10.7759/cureus.9639.
Article PubMed PubMed Central Google Scholar
Wilding JP. The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract. 2014;68(6):682–91. https://doi.org/10.1111/ijcp.12384.
Article CAS PubMed Google Scholar
Pownall HJ, Bray GA, Wagenknecht LE, Walkup MP, Heshka S, Hubbard VS, et al. Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2015;23(3):565–72. https://doi.org/10.1002/oby.21005.
Look ARG, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. https://doi.org/10.1056/NEJMoa1212914.
Alonso A, Bahnson JL, Gaussoin SA, Bertoni AG, Johnson KC, Lewis CE, et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial. Am Heart J. 2015;170(4):770-7 e5. https://doi.org/10.1016/j.ahj.2015.07.026.
Comments (0)